Intellipharmaceutics International Inc. (IPCI)

[tilator]

My take on the offering is it will be used to pay for Rexista HAP studies and day to day expenses for the next couple of months. My hope is it is enough to fund PODRAS first clinical human trials as well.

This is waste of money, because PH1 does not yet lead anywhere. Or actually it leads to a new offering.

I also believe Regabatin will not go anywhere until a partner is found. I think I heard at one point the PH3 trials on Regabatin would cost about $10-20M.

How come it would cost as much as PH3 with complete new active incredient?